Sherlock
Boswellia for lungs and MC stabllizing
- Messages
- 1,287
- Location
- k8518704 USA
@KIO Here is an article that gives an overview:
https://www.lef.org/magazine/2008/3/Protecting-Bone-And-Arterial-Health-With-Vitamin-K2/Page-01
Perhaps you have heard of LEF.org, which is the Life Extension Foundation. (Yes, they are also a supplement seller.) It's written by a cardiologist. People with osteoporosis seem to also have more calcium in their heart arteries than average, which represents a risk. (Yes, the author also has a book that he is selling.)
The idea is this: a person needs vitamin K2 to make sure that calcium goes to where it is wanted (bones and teeth) and does not go to where it is not wanted (arteries, kidneys, etc). The idea is not yet proven but it seems promising. From what I have seen, the most effective type to use is MK-7, from among the various kinds of vitamin K.
This study happens to use a Japanese food.
http://www.ncbi.nlm.nih.gov/pubmed/?term=15242015
https://www.lef.org/magazine/2008/3/Protecting-Bone-And-Arterial-Health-With-Vitamin-K2/Page-01
Perhaps you have heard of LEF.org, which is the Life Extension Foundation. (Yes, they are also a supplement seller.) It's written by a cardiologist. People with osteoporosis seem to also have more calcium in their heart arteries than average, which represents a risk. (Yes, the author also has a book that he is selling.)
The idea is this: a person needs vitamin K2 to make sure that calcium goes to where it is wanted (bones and teeth) and does not go to where it is not wanted (arteries, kidneys, etc). The idea is not yet proven but it seems promising. From what I have seen, the most effective type to use is MK-7, from among the various kinds of vitamin K.
This study happens to use a Japanese food.
http://www.ncbi.nlm.nih.gov/pubmed/?term=15242015
Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women.
Katsuyama H1, Ideguchi S, Fukunaga M, Fukunaga T, Saijoh K, Sunami S.
Author information
Abstract
A therapeutic agent of vitamin K2 is approved for the treatment of osteoporosis in Japan. However, little is known about the efficacy of dietary intake of vitamin K2 for bone health. We compared the effects of various levels of fermented soybeans (Natto) intake, which contains plenty of vitamin K2, on bone stiffness and bone turnover markers in healthy premenopausal women. Seventy-three healthy premenopausal women were randomly divided into four groups matched for age and parity categories. Natto was supplied as follows: Group 1 (no intake), Group 2 (once per month), Group 3 (once per week) and Group 4 (three times per week). Subjects took Natto at a lunch for 1 y, and the stiffness index by quantitative ultrasound and bone turnover markers were assessed at baseline, 6 mo and 1 y. There was no statistical difference in the stiffness index during the 1 y observation. However, bone specific alkaline phosphatase (BAP) in Group 4 was higher than that in Group 3 at 1 y and undercarboxylated osteocalcin (Glu) in Group 4 was significantly lower than those in Groups 1, 2 and 3 at 6 mo. Logistic regression analysis showed that the risk of reduction of bone formation markers declined to 0.07 in Group 4 based on that in Group 1. In premenopausal women who had to keep the stiffness index as high as possible before menopause, Natto intake may have contributed to the promotion of bone formation.